Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 12 | 12 | 0 |
| Shares | 2.26M | 4.30M | +2.04M (+90.3%) |
| Value | $12.1M | $10.5M | −$1.59M (−13.2%) |
New holders (7)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,929,876 | $4.69M | 0.11% |
| Vanguard Group Inc | 166,600 | $405.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 20,800 | $51.0K | 0.00% |
| Tudor Investment Corp Et Al | 18,148 | $44.0K | 0.00% |
| Citadel Advisors LLC | 12,597 | $31.0K | 0.00% |
| Wells Fargo & Company | 25 | $0 | 0.00% |
| Morgan Stanley | 2 | $0 | 0.00% |
Sold out (7)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Telemetry Investments, L.L.C. | 45,000 | $240.0K |
| Susquehanna International Group, LLP | 22,543 | $120.0K |
| Virtu Financial LLC | 17,704 | $94.0K |
| Cowen and Company, LLC | 10,000 | $53.0K |
| JPMorgan Chase & Co | 7,846 | $42.0K |
| Bank of America Corp | 100 | $1.00K |
| Royal Bank of Canada | 200 | $1.00K |